NSE
Dr. Lal Path Labs Ltd.LALPATHLAB
Dr Lal PathLabs is a leading diagnostics chain.
| Key products | Pathology and diagnostic testing services. |
|---|---|
| Geography | India (North-led). |
| Competitors | Metropolis, Agilus, Vijaya. |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 4 Per Share
ex 2026-06-25
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | LALPATHLABThis | — | — | — | — | — | — |
| 2 | CIPLA | — | — | — | — | +19 | 44 |
| 3 | DRREDDY | — | — | — | — | +20 | 46 |
| 4 | SUNPHARMA | — | — | — | — | +15 | 45 |
| 5 | TORNTPHARM | — | — | — | — | — | — |
| 6 | LUPIN | — | — | — | — | — | — |
| 7 | ZYDUSLIFE | — | — | 1 | +1 | — | — |
| 8 | APOLLOHOSP | — | — | 1 | — | — | — |
| 9 | AUROPHARMA | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-25ActionDividend - Rs 4 Per ShareDividend
- 2026-06-12FilingDr. Lal Path Labs Ltd. has informed the Exchange about General Updates- Update on Incorporation of Wholly OwneGeneral
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2GeneralNeutral
General Updates- Update on Incorporation of Wholly Owned Subsidiary Company
Source PDF →
No bulk/block deals for LALPATHLAB in this window.
News & chatter on LALPATHLAB
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.